Smoking is a risk factor for recurrence of intestinal stricture after endoscopic dilation in Crohn's disease
- 3 December 2012
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 37 (4), 430-437
- https://doi.org/10.1111/apt.12176
Abstract
Endoscopic balloon dilation is an efficacious and safe alternative to surgery as treatment of short intestinal strictures in Crohn's disease (CD). Factors predicting outcome of the procedure are not well described. To evaluate whether smoking at diagnosis, treatment with azathioprine, or other clinical variables may affect clinical outcome after endoscopic dilation. The endpoint was requirement of a new intervention such as dilation or surgery with intestinal resection or strictureplasty. Retrospective study of 83 patients with CD who underwent endoscopic balloon dilation of an intestinal stricture between 1987 and 2009. After index dilation 55/83 patients underwent a new intervention. Among current smokers, 31/32 (97%) underwent another intervention compared to 18/33 (55%) among never smokers (adjusted HR: 2.50, 95% CI: 1.14-5.50, P = 0.022). After 5 years, cumulative probability of new intervention was 0.81 in smokers compared to 0.52 in never smokers; difference 0.29 (95% CI: 0.07-0.52, P = 0.01). In 16 patients, therapy with azathioprine was initiated before or shortly after the index dilation; 7/16 underwent a new intervention compared to 48/67 of those without azathioprine (HR: 0.46, 95% CI: 0.21-1.03, P = 0.06). After adjustment for other variables, the association was even weaker (HR: 0.80, 95% CI: 0.29-2.18, P = 0.668). Sex, age at diagnosis, age at first dilation, balloon size, location of stricture, and treatment period did not influence outcome. Smoking doubles the risk of recurrent stricture formation requiring a new intervention after index dilation. Maintenance therapy with azathioprine did not influence the subsequent course and need for a new intervention.Keywords
This publication has 36 references indexed in Scilit:
- Review article: causative factors and the clinical management of patients with Crohn’s disease who lose response to anti-TNF-α therapyAlimentary Pharmacology & Therapeutics, 2011
- The response of Crohn’s strictures to endoscopic balloon dilationAlimentary Pharmacology & Therapeutics, 2010
- Long-term outcome of endoscopic dilatation in patients with Crohn's disease is not affected by disease activity or medical therapyGut, 2009
- Infliximab treatment for symptomatic Crohn’s disease stricturesAlimentary Pharmacology & Therapeutics, 2008
- Long-term prospective pilot study with tranilast for the prevention of stricture progression in patients with Crohn's diseaseGut, 2007
- Review article: smoking cessation as primary therapy to modify the course of Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2005
- Hydrostatic balloon dilatation of Crohn's stricturesAlimentary Pharmacology & Therapeutics, 2003
- Colonoscopic balloon dilation of Crohn's stricturesEuropean Journal of Gastroenterology & Hepatology, 2003
- Anti-TNF-Antikörper zur Therapie von entzündlichen Darmstenosen bei Morbus CrohnZeitschrift für Gastroenterologie, 2003
- Strictureplasty for Crohn's diseaseDiseases of the Colon & Rectum, 2000